Abstract
The improvement in the aqueous solubility, physicochemical and micromeritics property of insoluble and slightly soluble drugs is of major concern in pharmaceutical formulations. It is commonly observed in the durg industry that on average more than 35 % of newly discovered drugs are poorly water-soluble. Poor “drug like” properties of lead compounds led to ineffective absorption from the site of administration, less bioavailability which has been designated as an important part of the high clinical failure. In the present work, Carisoprodol, centrally acting skeletal muscle relaxant belongs to BCS class II drug (highly permeable and low soluble). A simultaneous differential scanning calorimetry (DSC), Fourier transforms infrared (FT-IR), XRPD microspectroscopy, SEM, dissolution study and micromeritics properties study was used to quickly investigate the co-crystal. Tablet formulation was developed by direct compression method and there evaluation was performed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
